AAAAAA

   
Results: 1-23 |
Results: 23
Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of the literature
Authors: Zeana, C Kubin, CJ Della-Latta, P Hammer, SM
Citation: C. Zeana et al., Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of the literature, CLIN INF D, 33(4), 2001, pp. 477-482
HIV fusion and its inhibition
Authors: LaBranche, CC Galasso, G Moore, JP Bolognesi, DP Hirsch, MS Hammer, SM
Citation: Cc. Labranche et al., HIV fusion and its inhibition, ANTIVIR RES, 50(2), 2001, pp. 95-115
Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial
Authors: Staszewski, S Keiser, P Montaner, J Raffi, F Gathe, J Brotas, V Hicks, C Hammer, SM Cooper, D Johnson, M Tortell, S Cutrell, A Thorborn, D Isaacs, R Hetherington, S Steel, H Spreen, W
Citation: S. Staszewski et al., Abacavir-lamivudine-zidovudine vs indinavir-lamivudine-zidovudine in antiretroviral-naive HIV-infected adults - A randomized equivalence trial, J AM MED A, 285(9), 2001, pp. 1155-1163
Virologic and regimen termination surrogate end points in AIDS clinical trials
Authors: Gilbert, PB DeGruttola, V Hammer, SM Kuritzkes, DR
Citation: Pb. Gilbert et al., Virologic and regimen termination surrogate end points in AIDS clinical trials, J AM MED A, 285(6), 2001, pp. 777-784
Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection.
Authors: Albrecht, MA Bosch, RJ Hammer, SM Liou, SH Kessler, H Para, MF Eron, J Valdez, H Dehlinger, M Katzenstein, DA
Citation: Ma. Albrecht et al., Nelfinavir, efavirenz, or both after the failure of nucleoside treatment of HIV infection., N ENG J MED, 345(6), 2001, pp. 398-407
Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy
Authors: Lathey, JL Tierney, C Chang, SYP D'Aquila, RT Bettendorf, DM Alexander, HC Santini, CD Hughes, AM Barroga, CF Spector, SA Landes, JE Hammer, SM Katzenstein, DA
Citation: Jl. Lathey et al., Associations of CCR5, CCR2, and stromal cell-derived factor 1 genotypes with human immunodeficiency virus disease progression in patients receiving nucleoside therapy, J INFEC DIS, 184(11), 2001, pp. 1402-1411
Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine - AIDS clinical trials group protocol 320
Authors: Demeter, LM Hughes, MD Coombs, RW Jackson, JB Grimes, JM Bosch, RJ Fiscus, SA Spector, SA Squires, KE Fischl, MA Hammer, SM
Citation: Lm. Demeter et al., Predictors of virologic and clinical outcomes in HIV-1-infected patients receiving concurrent treatment with indinavir, zidovudine, and lamivudine - AIDS clinical trials group protocol 320, ANN INT MED, 135(11), 2001, pp. 954-964
Host determinants in HIV infection and disease part 1: Cellular and humoral immune responses
Authors: Hogan, CM Hammer, SM
Citation: Cm. Hogan et Sm. Hammer, Host determinants in HIV infection and disease part 1: Cellular and humoral immune responses, ANN INT MED, 134(9), 2001, pp. 761-776
Host determinants in HIV infection and disease - Part 2: Genetic factors and implications for antiretroviral therapeutics
Authors: Hogan, CM Hammer, SM
Citation: Cm. Hogan et Sm. Hammer, Host determinants in HIV infection and disease - Part 2: Genetic factors and implications for antiretroviral therapeutics, ANN INT MED, 134(10), 2001, pp. 978-996
Differences between women and men in adverse events and CD4(+) responses to nucleoside analogue therapy for HIV infection
Authors: Currier, JS Spino, C Grimes, J Wofsy, CB Katzenstein, DA Hughes, MD Hammer, SM Cotton, DJ
Citation: Js. Currier et al., Differences between women and men in adverse events and CD4(+) responses to nucleoside analogue therapy for HIV infection, J ACQ IMM D, 24(4), 2000, pp. 316-324
Antiretroviral resistance testing comes of age
Authors: Hammer, SM Pedneault, L
Citation: Sm. Hammer et L. Pedneault, Antiretroviral resistance testing comes of age, ANTIVIR TH, 5(1), 2000, pp. 23-26
Both serum HIV type 1 RNA levels and CD4(+) lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4(+) cells per cubic millimeter
Authors: Kim, S Hughes, MD Hammer, SM Jackson, JB DeGruttola, V Katzenstein, DA
Citation: S. Kim et al., Both serum HIV type 1 RNA levels and CD4(+) lymphocyte counts predict clinical outcome in HIV type 1-infected subjects with 200 to 500 CD4(+) cells per cubic millimeter, AIDS RES H, 16(7), 2000, pp. 645-653
Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine
Authors: Albrecht, MA Hughes, MD Liou, SH Katzenstein, DA Murphy, R Balfour, HH Para, MF Valdez, H Hammer, SM
Citation: Ma. Albrecht et al., Effect of lamivudine in HIV-infected persons with prior exposure to zidovudine/didanosine or zidovudine/zalcitabine, AIDS RES H, 16(14), 2000, pp. 1337-1344
The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of <= 50 x 10(6) cells/l
Authors: Coakley, EPG Samore, MH Gillis, JM Hughes, MD Hammer, SM
Citation: Epg. Coakley et al., The values of quantitative serum HIV-1 RNA levels and CD4 cell counts for predicting survival time among HIV-positive individuals with CD4 counts of <= 50 x 10(6) cells/l, AIDS, 14(9), 2000, pp. 1147-1153
Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine
Authors: Coakley, EP Gillis, JM Hammer, SM
Citation: Ep. Coakley et al., Phenotypic and genotypic resistance patterns of HIV-1 isolates derived from individuals treated with didanosine and stavudine, AIDS, 14(2), 2000, pp. F9-F15
Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel
Authors: Carpenter, CCJ Cooper, DA Fischl, MA Gatell, JM Gazzard, BG Hammer, SM Hirsch, MS Jacobsen, DM Katzenstein, DA Montaner, JSG Richman, DD Saag, MS Schechter, M Schooley, RT Vella, S Yeni, PG Volberding, PA
Citation: Ccj. Carpenter et al., Antiretroviral therapy in adults - Updated recommendations of the International AIDS Society-USA Panel, J AM MED A, 283(3), 2000, pp. 381-390
Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel
Authors: Hirsch, MS Brun-Vezinet, F D'Aquila, RT Hammer, SM Johnson, VA Kuritzkes, DR Loveday, C Mellors, JW Clotet, B Conway, B Demeter, LM Vella, S Jacobsen, DM Richman, DD
Citation: Ms. Hirsch et al., Antiretroviral drug resistance testing in adult HIV-1 infection - Recommendations of an International AIDS Society-USA panel, J AM MED A, 283(18), 2000, pp. 2417-2426
A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection - Conducting clinical HIV trials in South-East Asia
Authors: Phanuphak, P Grayson, ML Sirivichayakul, S Suwanagool, S Ruxrungtham, K Hanvanich, M Ratanasuwan, W Ubolyam, S Hughes, MD Wanke, CA Hammer, SM
Citation: P. Phanuphak et al., A comparison of two dosing regimens of zidovudine in Thai adults with early symptomatic HIV infection - Conducting clinical HIV trials in South-East Asia, AUST NZ J M, 30(1), 2000, pp. 11-20
Clinical trials using HIV-1 RNA-based primary endpoints: Statistical analysis and potential biases
Authors: Marschner, IC Betensky, RA DeGruttola, V Hammer, SM Kuritzkes, DR
Citation: Ic. Marschner et al., Clinical trials using HIV-1 RNA-based primary endpoints: Statistical analysis and potential biases, J ACQ IMM D, 20(3), 1999, pp. 220-227
The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements
Authors: Brambilla, D Reichelderfer, PS Bremer, JW Shapiro, DE Hershow, RC Katzenstein, DA Hammer, SM Jackson, B Collier, AC Sperling, RS Fowler, MG Coombs, RW
Citation: D. Brambilla et al., The contribution of assay variation and biological variation to the total variability of plasma HIV-1 RNA measurements, AIDS, 13(16), 1999, pp. 2269-2279
Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells
Authors: Bier, M Hammer, SM Canaday, DJ Lee, RC
Citation: M. Bier et al., Kinetics of sealing for transient electropores in isolated mammalian skeletal muscle cells, BIOELECTROM, 20(3), 1999, pp. 194-201
Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand
Authors: Wanke, CA Cohan, D Thummakul, T Jongwuitiwes, S Grayson, ML Hammer, SM Hanvanich, M
Citation: Ca. Wanke et al., Diarrheal disease in patients infected with human immunodeficiency virus in Bangkok, Thailand, AM J TROP M, 60(5), 1999, pp. 871-874
Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial
Authors: Simpson, DM Katzenstein, DA Hughes, MD Hammer, SM Williamson, DL Jiang, Q Pi, JT
Citation: Dm. Simpson et al., Neuromuscular function in HIV infection: analysis of a placebo-controlled combination antiretroviral trial, AIDS, 12(18), 1998, pp. 2425-2432
Risultati: 1-23 |